SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001764013-22-000126
Filing Date
2022-10-04
Accepted
2022-10-04 16:27:14
Documents
1
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166491518472332.html 4  
1 FORM 4 wf-form4_166491518472332.xml 4 4668
  Complete submission text file 0001764013-22-000126.txt   6142
Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Pande Atul (Reporting) CIK: 0001643071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38906 | Film No.: 221292033

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences